Search
Close this search box.

2020 Presentations

Ryan Maddox, PhD, Epidemiologist, CDC

Watch Presentation: 2020 CDC Update on Prion Disease

Download Presentation

Simon Mead, Consultant Neurologist & Clinical Lead, UK National Prion Clinic, National Hospital for Neurology & Neurosurgery

Watch Presentation: Genetic Prion Disease and How Genetics Might Help Us Understand Sporadic CJD

Download Presentation

Anne Smith, Executive Director, Clinical Development at Ionis Pharmaceuticals

Watch Presentation: Antisense Oligonucleotides for Prion Disease

Brian Appleby, MD, Medical Director, CJD Foundation, and Director, National Prion Disease Pathology Surveillance Center

Watch Presentation: National Prion Disease Pathology Surveillance Center Update

CJD Foundation Research Grant Recipient Reports Panel 1

  • Sonia Vallabh, PhD, Broad Institute of MIT and Harvard
    Assessing efficacy of zinc-finger repressors of prion protein as a therapeutic for prion disease
  • Dr. Holger Wille, University of Alberta
    Evaluating prion vaccines in transgenic mouse models of familial prion diseases

Watch Presentation

CJD Foundation Research Grant Recipient Reports Panel 2

  • Fei Wang, PhD, The University of Texas Health Science Center at Houston
    Generating Recombinant Human Prions in Large Scale for Structural Studies
  • Rodrigo Morales, PhD, The University of Texas Health Science Center at Houston
    Exploring the zoonotic potential of porcine-derived materials from animals exposed to infectious prions
  • Dr. Gabriel Haller and Brooke Sadler, PhD, Washington University School of Medicine
    The Contribution of Rare Variant and Copy-Number Variation to Risk of Sporadic CJD and Pleiotropy with Other Neurodegenerative Diseases
  • Candace Mathiason, PhD, Prion Research Center, Colorado State University
    Use of Blood-borne Prion Amplification Assays for the Detection of Human Prion Diseases and Biomarker Assessment

Watch Presentation

CJD Foundation Research Grant Recipient Reports Panel 3

  • Anna Poleggi, PhD, Istituto Superiore di Sanità, Rome
    Investigating the influence of CYP4X1 gene of age at the onset of CJD as a potential preventive therapeutic approach
  • Qingzhong Kong, PhD, Case Western Reserve University
    The RAP approach for effective prevention and treatment of prion diseases
  • Natalia do Carmo Ferreira de Araujo, PhD, Rocky Mountain Laboratories, NIH/NIAID
    Evaluation of new anti-prion drugs: from drug design to therapeutic efficacy against human prions in vitro, ex-vivo and in vivo

Watch Presentation